+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes



Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes



Future Cardiology 12(4): 449-466



Despite attaining LDL-cholesterol targets, many patients with diabetes remain at risk of developing cardiovascular events. In addition, treatment with statins has been associated with a slight but significant increased risk of development of diabetes, particularly with high-intensity statins. Pitavastatin is a moderate- to high-intensity statin that effectively reduces LDL-cholesterol levels. Pitavastatin provides a sustained increase of HDL-cholesterol levels that may exhibit a neutral or positive effect on glucose metabolism, may not increase the risk of new-onset diabetes, may exhibit positive effects on renal function and urinary albumin excretion and the risk of drug-drug interactions is low. Therefore, it seems that pitavastatin should preferentially be considered in the treatment of dyslipidemia in diabetic patients or at risk of developing diabetes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 057420415

Download citation: RISBibTeXText

PMID: 27076402

DOI: 10.2217/fca-2016-0018


Related references

Focus on the clinical ramifications of antipsychotic choice for the risk for developing type 2 diabetes mellitus. International Journal of Neuropsychopharmacology 8(2): 147-151, 2005

Effect of pitavastatin on glucose, HbA1c and incident diabetes: A meta-analysis of randomized controlled clinical trials in individuals without diabetes. Atherosclerosis 241(2): 409-418, 2015

Are spouses of patients with type 2 diabetes at increased risk of developing diabetes?. Diabetes Care 26(3): 710-712, 2003

Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more?. Diabetes Care 29(3): 543-548, 2006

Sexual dimorphism in the risk for developing insulin treated diabetes among relatives to diabetes patients diagnosed between 15 and 34 years of age. Diabetologia 46(Suppl. 2): A54, 2003

Statin use and the risk of developing diabetes. Study confirms a link, but does the risk outweigh the benefits?. Johns Hopkins Medical Letter Health After 50 24(2): 1-2, 2012

Gestational diabetes mellitus: clinical predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using survival analysis. Diabetes Care 30(4): 878-883, 2007

Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrology Dialysis Transplantation 23(4): 1278-1284, 2008

Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies. Current Medical Research and Opinion 30(5): 775-784, 2014

The impact of training modalities on the clinical benefits of exercise intervention in patients with cardiovascular disease risk or type 2 diabetes mellitus. Sports Medicine 40(11): 921-940, 2010

Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes. Diabetes Care 24(9): 1547-1555, 2001

Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk. Diabetes Care 32(10): 1823-1825, 2009

Japan Prevention Trial of Diabetes by Pitavastatin in Patients with Impaired Glucose Tolerance the J-PREDICT study rationale, study design, and clinical characteristics of 1269 patients. Diabetology International 2(3): 134-140, 2011

Associations between dietary fiber and inflammation, hepatic function, and risk of type 2 diabetes in older men: potential mechanisms for the benefits of fiber on diabetes risk: response to wannamethee et Al. Diabetes Care 33(3): E43; Author Reply E44, 2010

Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 35(3): 565-573, 2012